Walter Desmet, MD PhD, Christophe Dubois, MD PhD

Slides:



Advertisements
Similar presentations
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
Advertisements

29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Stent Assisted Balloon Induced Intimal Disruption and Relamination in Aortic Dissection Repair: The STABILISE Concept Sophie C. Hofferberth 1, Andrew E.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
OCT findings in bifurcations Nanjing first hospital Chen shaoliang Zhu zhongsheng.
Dedicated Bifurcation Stent Technology: Implications for Everyday Practice Jens Flensted Lassen MD, PH.D., FESC The Heart Centre, Rigshospitalet University.
Tryton Pivotal IDE-RCT Results Implications For Everyday Practice Integrating Dedicated Technology Antonio L. Bartorelli, FACC, FESC Centro Cardiologico.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Short-Term Clinical Outcomes of Small.
The REVA Tyrosine-Derived Polycarbonate Bioresorbable Scaffold: Long-term Outcomes Using Multimodality Imaging Greg L. Kaluza, MD, PhD, FACC Director of.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparative Analysis of Sequential Proximal Optimizing.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Severe Neointimal Hyperplasia of Neoplastic Carina.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Kissing Balloon or Sequential Dilation of the Side.
Disclosure Statement of Financial Interest
Martin B. Leon, MD Key Messages Tryton Pivotal: Randomized Trial and
Issues and Current Situations in the Development of Endovascular Treatment Devices for Pediatric Cardiology in the US – US Industry Dan Gutfinger, MD,
Disclosures Runlin Gao has received a research grant
My initial ABSORB experience Assoc. Prof. I. Petrov
Latvian Centre of Cardiology real-life registry
Runlin Gao, M.D. On behalf of ABSORB China Investigators
New Stent Designs Applicable for Renal Intervention
Bifurcation Balloon & Stent Delivery System
Invasive Assessment of Coronary Artery Disease
Abbott Vascular Bifurcation Program
on behalf of the ABSORB II Investigators
Bifurcation Management Update:
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
BRANCH Bare Metal BifuRcAtion SteNt Clinical Trial in Humans Early Clinical Experience by Raoul Bonan, MD On behalf of the BRANCH study investigators.
Regulatory Challenges for Bioasorbable Stent Approval
Bioresorbable Scaffolds: State of the Field and Lessons Learned
Clinical Presentation
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
Strategy planning in coronary bifurcation stenting
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Meruzhan Saghatelyan, MD, Interventional cardiologist
Summary and Conclusion
ABSORB Japan: 3-year Clinical and Angiographic Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting.
The Tryton Bifurcation Trial:
Greg L. Kaluza, MD, PhD, FACC Cardiovascular Research Foundation
DES Bioabsorbable and DCB Technologies
BRS Summit – Scaffold Fractures
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
BVS Expand: First Results of Wide Clinical Applications
The XIENCE V EXCEED Study
TCT 2016, Washington convention center
Subintimal Tracking and Reentry for CTO STAR Method
OCT-Guided PCI What needs to be done to establish criteria?
Fig. 2. Revascularization for CTO in RCA
William Wijns MD PhD Thomas Cuisset MD
on behalf of the ABSORB II Investigators
Fig. 3. After BVS implantation
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
A novel application of the culotte stent technique to bail out a jailed common iliac artery  Hideto Sangen, MD, Shuhei Tara, MD, PhD, Takahisa Tanaka,
Intraprocedural imaging: Thoracic aortography techniques, intravascular ultrasound, and special equipment  Rodney A. White, MD, Carlos E. Donayre, MD,
Outcomes of a novel technique of endovascular repair of aneurysmal internal iliac arteries using iliac branch devices  Martin Austermann, MD, Theodosios.
Ana Rita Ramalho et al. JCIN 2017;10:
Intracoronary imaging to guide percutaneous coronary intervention: Clinical implications  Giancarla Scalone, Giampaolo Niccoli, Omar Gomez Monterrosas,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Figure 5 Bioresorbable vascular scaffold apposition and strut coverage
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.
Fadi J. Sawaya et al. JCIN 2016;9:
APPROACH TO CORONARY BIFURCATION LESIONS
(p for non-inferiority < 0.001)
Vladimír Džavík, and Antonio Colombo JCIN 2014;7:81-88
Tanveer Rab et al. JCIN 2017;10:
Implantation of a Sapien XT aortic bioprosthesis with the NovaFlex catheter through a subclavian access  Bertrand Marcheix, MD, PhD, Etienne Grunenwald,
Presentation transcript:

Walter Desmet, MD PhD, Christophe Dubois, MD PhD The Absorb Bioresorbable Vascular Scaffold in coronary bifurcations: an in-vivo multi-modality imaging study Johan Bennett, MD, Maarten Vanhaverbeke, MD, Nina Vanden Driessche, Tom Adriaenssens, MD PhD, Peter Sinnaeve, MD PhD, Walter Desmet, MD PhD, Christophe Dubois, MD PhD Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium Department of Cardiovascular Sciences, Catholic University Leuven, Leuven Belgium Financial Disclosures; J Bennett; Fee/Honoraria/Speaker’s Bureau for St-Jude Medical, Medtronic ; T Adriaenssens; Fee/Honoraria/Speaker’s Bureau for St-Jude Medical; P Sinnaeve; Fee/Honoraria/Speaker’s Bureau for Abbott, Cordis; C Dubois Fee/Honoraria/Speaker’s Bureau for Medtronic, Boston Scientific and Edwards LifeSciences Background Bioresorbable scaffolds (BRS) represent a promising new technology that theoretically can eliminate the late and very late stent thrombosis observed after deployment of metal DESs because, at some point, the physical material that could potentially provide a nidus for a stent-related thrombotic event completely disappears. However, the Absorb BVS has yet to be evaluated in patients with planned treatment of true bifurcation lesions because, unlike a metal stent, this polymeric BVS can unravel when deployed beyond recommended diameter limits and there are concerns that the integrity of the scaffold may be compromised by common techniques required during 2 stent bifurcation techniques such as recrossing, proximal optimization and kissing balloon dilatations. This in-vivo study sought to provide insights regarding the feasibility and safety of performing complex bifurcation techniques with the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS, Abbott Vascular, Santa Clara, California). Results (Table 1 + 2) In all 20 procedures angiographic results were excellent with no evidence of dissection or SB compromise. Re-crossing through BVS struts with guidewires was always successful and subsequent crossing with balloons and a second BVS (only in TAP + culotte procedures) was smooth. Provisional stenting (n=5) optimally opened the SB ostium without deforming the MV BVS. On OCT there was no malapposition in the MV and micro-CT revealed good SB aperture and a single connector fracture was present in the MV in 1 of the 5 cases (fig 1). Modified T stenting (fig 3, SB stented first, n=5) and TAP stenting (fig 4, MV stented first, n=5) resulted in complete coverage of the SB ostium and carina. Both techniques resulted in minimal double-strut layers at the carina and at the proximal SB ostium on OCT with no significant malapposition. On Micro-CT, no strut fractures were present following modified T stenting (fig 5), whilst in 3 out of 5 TAP procedures single strut fractures were noted, these did not cause luminal compromise. Culotte stenting (n=5) resulted in complete coverage of the bifurcation with an extensive proximal segment of double-layered scaffold struts. In 3 of the 5 culotte procedures, OCT revealed significant malapposition at the level of the bifurcation (fig 2). On micro-CT there was distortion of MV and SB scaffolds at the level of the bifurcation with single strut fractures present in all 5 cases affecting the MV BVS. These fractures did not cause luminal compromise though did increase the aperture between subsequent hoops. . Methods The study protocol was evaluated and approved by the ethical board for animal research of the University of Leuven. The experiments were performed in an in-vivo rabbit non-diseased aorta-iliac bifurcation model. Under general anaethesia (Xylazine and Ketamine), 20 New Zealand adult white rabbits (weight 3.5-4.4 kg) underwent bifurcation interventions of the aorta-iliac bifurcation. Arterial access was achieved by denuding the carotid artery and introducing a long 6Fr sheath to the distal descending aorta. Absorb Everolimus-eluting BVS version 1.1 (3.0x24 mm) were implanted in single or 2-stent strategies. Optical coherence tomography (OCT) pullbacks were recorded in vivo using the IlumienTM IVOCT system and DragonflyTM catheters or the Optis system with DragonFly Duo catheters (St Jude Medical, St Paul, MN, USA). All images were stored for off-line analysis. Following the completion of the bifurcation procedure and OCT examinations, the animal was sacrificed and the aorta-iliac bifurcation was dissected out and stored in 4% formol. Thereafter, micro-computed tomography (micro-CT) was performed using the SkyScan 1076 in-vivo micro-CT ( SkyScan/Bruker-microCT, Kontich, Belgium). The following bifurcation techniques were investigated: provisional stenting with final mini-kiss balloon post-dilatation (FKBD, n=5), modified T stenting with mini-FKBD (n=5), Culotte with mini-FKBD (n=5) and T-and Protrusion with mini-FKBD (n=5). Proximal Optimisation Technique (POT) was always performed using 3.5 mm NC balloons to 16 atm. Figure 3 Figure 4 OCT images after Modified-T (fig 3) and TAP (fig 4) procedures  Table 1: Procedure end OCT analysis PROVISIONAL (n=5) MOD T TAP CULOTTE Procedure succes 100% Device succes OCT assessment   Scaffold CSA (mm2) Prox MV 10.1 ± 0.6 10.7 ± 2.0 10.9 ± 1.2 11.2 ± 0.2 Ostial distal MV 7.9 ± 1.0 8.1 ± 1.0 7.5 ± 0.5 8.4 ± 0.8 Ostial SB 8.3 ± 2.3 7.9 ± 0.4 8.2 ± 1.0 7.4 ± 3.1 Scaffold mean CSD (mm) 3.6 ± 0.1 3.7 ± 0.4 3.7 ± 0.2 3.8 ± 0.0 3.2 ± 0.1 3.2 ± 0.2 3.1 ± 0.1 3.3 ± 0.2 3.3 ± 0.5 Complete coverage bifurcation - 4/5 5/5 Malappostion 1/5 0/5 Distal MV SB Bifurcation MV scaffold 3/5 SB scaffold Both - Visible strut fracture  Table 2: Micro-CT analysis PROVISIONAL (n=5) MOD T TAP CULOTTE 1. Proximal MV scaffold - Strut fracture/elongation 0/5 2. Distal MV scaffold   3. SB scaffold n/a 4. Bifurcation (POC) zone - Multiple strut fractures - Single strut fracture 1/5 3/5 5/5 MV scaffold 2/5 4/5 - Hoop - - Connector SB scaffold - Luminal compromise  1/5 Figure 5: 3D micro-CT reconstruction of Modified-T procedure Conclusion In this non-diseased in-vivo aorto-iliac bifurcation model, it was feasible to perform complex bifurcation stenting using Absorb BVS with excellent angiographic results. Provisional stenting of the main vessel with additional TAP stenting whenever needed seems a reasonable standard approach for most bifurcation lesions. Whenever a 2-stent technique is planned from the outset, modified T-stenting was the most promising with no evidence of significant malapposition or scaffold disruption on OCT and micro-CT, respectively. Finally, culotte stenting frequently caused significant malapposition, scaffold distortion and single strut fractures, the clinical impact of which is unknown.   Figure 1 Figure 2 OCT images after provisional (fig 1) and Culotte (fig 2) procedures